Early experience withp-(N,N-di-2-chloroethyl)-aminophenylbutyric acid (CB 1348), a new chemotherapeutic agent effective in the treatment of chronic lymphocytic leukemia

This publication has 17 references indexed in Scilit:

• Clinical Trials of p-(Di-2-chloroethylamine)-phenylbutyric Acid (CB 1348) in Malignant Lymphoma
  BMJ, 1955
• Clinical and hematologic effects of triethylene melamine
  The American Journal of Medicine, 1953
• TREATMENT OF CHRONIC LEUKEMIAS
  JAMA, 1952
• Triethylene melamine in clinical cancer chemotherapy
  The American Journal of Medicine, 1952
• ALKYLAMINES IN THE TREATMENT OF LEUKÆMIA
  The Lancet, 1952
• TRIETHYLENE MELAMINE IN THE TREATMENT OF NEOPLASTIC DISEASE
  A.M.A. Archives of Internal Medicine, 1951
• TITRATED, REGULARLY SPACED RADIOACTIVE PHOSPHORUS OR SPRAY ROENTGEN THERAPY OF LEUKEMIAS
  Archives of internal medicine (1960), 1951
• The place of radiotherapy in the treatment of chronic lymphoid leuk˦mia
  Journal of the Faculty of Radiologists, 1949
• The nitrogen mustards in the treatment of leukemia
  Cancer, 1949
• RESULTS OF CONSERVATIVE APPLICATION OF X-RAY TREATMENT IN CHRONIC LEUKEMIA
  JAMA, 1940